FEATURED ARTICLES

• Preventive Maintenance Isn't Enough For GMP Manufacturers

  Schedule‑based maintenance supports compliance but misses real‑time asset risk. Explore how GMP manufacturers are moving toward condition‑based and predictive strategies to modernize asset management.

• Proactive EAM Automation For Compliance And Efficiency

  Proactive compliance depends on automation. When asset data drives investigations, enforces change control, and reveals hidden failure patterns, compliance becomes an outcome of strong operations.

• 5 Ways GMP Manufacturers Can Start Improving Asset Performance Today

  In GMP operations, poor asset control quickly becomes a compliance risk. Learn how maintenance and calibration gaps lead to deviations and why demonstrable asset performance is essential.

• Site Expansion Without Added Compliance Risk

  Multi-site expansion doesn’t require rebuilding maintenance and calibration programs from scratch. What matters is standardized work, reliable data, and clear oversight that holds up in every facility.

• Which Implementation Model Fits Your Reality?

  CMMS and EAM go-lives in GMP environments hinge on more than timing. Explore how big-bang, phased, compliance-first, and patchwork approaches shift validation effort, audit risk, and operational strain.

• SaaS Updates Don't Have To Break Your Validated State

  SaaS updates don’t have to mean full revalidation. Learn how to apply CSA principles to assess vendor updates, right-size regression testing, and document decisions that hold up under regulatory scrutiny.

• Site Expansion Success Blueprint

  Discover how a global pharmaceutical manufacturer unified six sites under one asset management strategy, improving compliance and scalability to help teams plan, prepare data, and expand confidently.

• How A New Partnership Is Making Compliance Easier For Life Sciences Teams

  When compliance gaps disrupt equipment programs, the consequences show up fast. Learn how pairing digital systems with practical expertise helps teams standardize processes and stay inspection-ready.

• After Go-Live: A GMP Playbook For Vendor Partnership

  After go-live, system risk increases. Examine how ongoing validation, controlled change, and reliable issue resolution determine whether a system stays compliant or becomes a liability.

• Building Training Programs And User Controls That Last Beyond Go-Live

  Validation success doesn’t guarantee audit readiness. When training fades, compliance risk grows quietly. Learn how post-go-live gaps surface and how programs prevent findings before auditors do.

• Bring All Your Sites Under One CMMS Technology Roof

  Many organizations are moving to a single CMMS to streamline maintenance. Learn why harmonizing asset management systems across sites is becoming essential in life sciences operations.

• The 2026 Compliance Feature Checklist

  Generic compliance claims create risk. This checklist turns Part 11 expectations into testable criteria, demo-ready scenarios, and RFP language—so teams can avoid validation surprises.

• How To Choose A GXP Electronic System Vendor

  Selecting a GxP electronic system impacts validation timelines and audit readiness. See how purpose-built platforms simplify compliance, while heavily customized generic tools often introduce risk.

• Quality Over Checkbox Compliance: From QRM To Quality Maturity

  Quality maturity shifts asset management from compliance-focused to risk-based. Discover how performance-driven calibration and leading indicators create systems where quality outcomes become inevitable.

• 5 Costly Consequences Of FDA Non-Compliance

  See how automated maintenance systems help pharma manufacturers avoid FDA citations, preserve client relationships, and build the documented reliability that wins competitive contracts.

• Managing Compliance Risks With Cloud-Native EAM/CMMS

  What separates systems that maintain compliance effortlessly from those that struggle? Test mobile offline signatures, automated OOT workflows, and integration traceability during vendor evaluations.

• FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy

  Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.

• Choosing 21 CFR Part 11 Software: A Practical Buyer's Guide

  Electronic records require audit trails, two-component signatures, authority checks, and ALCOA+ controls. See how to evaluate Part 11 software, build validation packages, and maintain inspection readiness.

• The Complete Guide To Computer System Validation

  Understand the three-phase validation protocol that proves computer systems meet FDA requirements for accuracy, security, and reliability under 21 CFR Part 11 compliance standards.

• Unifying EAM And ERP: Transform Asset Management In Life Sciences

  Fragmented systems create compliance risks and operational inefficiencies. Learn how integrated asset management and ERP platforms eliminate duplicate work while maintaining audit-ready documentation.